<DOC>
	<DOC>NCT02260830</DOC>
	<brief_summary>The purpose of this study is to investigate the pharmacokinetic (PK) properties of various modified release tablet formulations of Lu AF11167 (Part A) and to investigate the pharmacokinetic (PK) properties of a modified release tablet formulation of Lu AF11167 in a fed and fasted state and following multiple dosing (Part B).</brief_summary>
	<brief_title>Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Healthy men and women ≥18 and ≤45 years of age with a body mass index (BMI) of &gt;18.5 and &lt;30.0 kg/m2. Women of childbearing potential will have a confirmed nonpregnant and nonlactating status. Other predefined inclusion and exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>